Cancer News - Treatment Options

Chemoprevention one option in prostate cancer screening advice
Physicians warn that such discussions may crowd out messages about more effective health strategies.

Counseling about prostate cancer screening could become more complex, but some parts of the message are increasingly straightforward. For instance, the majority of men can be told they will be able to end testing after age 75, according to medical society guidelines and a study published in March and April.

http://www.ama-assn.org/amednews/2009/03/16/hlsb0316.htm

MRI And PET/CT Improve Cervical Cancer Patient's Chances For Optimal Treatment

ScienceDaily (Mar. 4, 2009) — Pretreatment MRI and PET/CT for cervical cancer may direct more women to optimal therapy choices and spare many women potential long-term morbidity and complications of trimodality therapy (surgery followed by chemoradiation), according to a study performed at the Institute for Technology Assessment in Boston, MA.

http://www.sciencedaily.com/releases/2009/03/090304091233.htm

Younger Breast Cancer Patients Have Greater Chance Of Recurrence, Especially After Certain Treatments

ScienceDaily (Mar. 4, 2009) — Breast cancer patients 35 years old and younger have higher rates of their cancer returning after treatment than older women patients with the same stage of cancer, and their risk of recurrence is greatly impacted by the type of treatment they received, according to a March 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

http://www.sciencedaily.com/releases/2009/03/090304144302.htm

New Cancer Treatment Stops Aggressive Sarcomas

After all standard treatments had failed, a new cancer treatment has stopped the growth of aggressive sarcomas in two recent patients. These results are similar to the new protocol's previous success against several cancers, including melanoma, pancreatic, colon, mesothelioma and other sarcomas.

http://www.medilexicon.com/medicalnews.php?newsid=140309

Safe, Well-tolerated, And Effective Treatment For Metastatic Esophageal Cancer

ScienceDaily (Feb. 21, 2009) — Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis.

http://www.sciencedaily.com/releases/2009/02/090223091759.htm

Discovery Boosts Cancer Radiation Therapy Effectiveness

Dr. Gino Fallone and his team of medical physicists at the Cross Cancer Institute in Edmonton are the first in the world to successfully take a magnetic resonance (MR) image at the same time radiation therapy is being delivered.

http://www.medicalnewstoday.com/articles/139713.php

New Standard for Prostate Cancer Treatment?

Men with locally advanced prostate cancer – that is, men whose cancer has spread beyond the wall of the prostate gland – responded better to a combination of radiation plus long-term hormone therapy than men who received hormone therapy alone, according to results from a large phase III study by Swedish researchers. In fact, the combined treatment cut the men’s risk of death in half.

http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Radiation__Hormone_Th...

Diagnostic procedure will help doctors better target breast cancer treatments

ST. LOUIS — A test to identify the complex differences in breast tumors could be available later this year to help doctors better understand how to treat their patients, researchers at Washington University in St. Louis said Monday.

http://www.twincities.com/alllistings/ci_11670239?source=rss

Locoregional radiotherapy improves survival in Stage IV breast cancer

MedWire News: Locoregional treatment (LRT), and in particular locoregional radiotherapy (LRR), is associated with improved survival in breast cancer patients with synchronous metastases, a study shows.

http://www.medwire-news.md/46/80751/Oncology/Locoregional_radiotherapy_i...

New Test For Breast Cancer Will Help Guide Treatment Choices

One in eight women in the United States will receive a diagnosis of breast cancer in their lifetime, and it is the second leading cause of cancer-related death in women. Now a new test will help physicians determine the best possible treatment for each patient.

http://www.medicalnewstoday.com/articles/138420.php